FBDIX Mutual Fund

FBDIX Mutual Fund (Franklin Biotechnology Discovery Fund Class A) is managed by Franklin Templeton Investments (US) with $924.8M in net assets. FBDIX expense ratio is 1.02%, holding 98 positions across sectors including Health Care, Financials. Inception date: 1997-09-15.

FBDIX performance shows a YTD return of 17.77%. The 1-year return is 71.44% and the 5-year return is 11.81%. FBDIX dividend yield stands at 1.81%, paid annually.

FBDIX top holdings include Gilead Sciences (6.2%), Amgen Inc. (4.8%), Nvaesrtex Pharmaceuticals Inc (4.7%), Jazz Pharmaceuticals Plc. (4.6%), Regeneron Pharmaceuticals, Inc. (4.4%). Go to all FBDIX holdings, FBDIX sectors, or FBDIX dividends.

FBDIX can be compared against other funds. Use FBDIX overlap to find shared positions, or FBDIX vs another fund for a side-by-side view. FBDIX alternatives are available via the screener, along with tax-loss harvesting opportunities.